Navigation Links
Aurobindo Pharma USA, Inc. Issues Voluntary Nationwide Recall of Northstar Label Gabapentin Capsules, USP 300 mg Due to Complaints of Empty Capsules
Date:11/23/2014

DAYTON, N.J., Nov. 23, 2014 /PRNewswire/ -- Aurobindo Pharma USA is voluntarily recalling lot GESB14011-A of Gabapentin Capsules, USP 300 mg 100-count bottles to the consumer level. The product lot has been found to contain some empty capsules.

Empty capsules could result in missed dose(s) of gabapentin resulting in adverse health consequences that could range from no effect, short term reduction in efficacy, short term withdrawal effect, or status epilepticus (long period seizures) that could be life-threatening. Aurobindo Pharma USA, Inc. has not received any reports of adverse events related to this recall to date, but has received four complaints for empty capsules.

Gabapentin is used as in the treatment of epilepsy and for the management of postherpetic neuralgia (pain after shingles). The affected Gabapentin lot is GESB14011-A, Expiration 12/2015 and is packaged in 100-count bottles, NDC 16714-662-01. The product can be identified by the imprint D on yellow cap and 03 on yellow body with black edible ink. Product was distributed through Northstar label to retail outlets nationwide.

Aurobindo Pharma USA, Inc. is notifying its distributors and customers by recall letters and is arranging for return of all recalled product. Consumers, distributors, and retailers that have product which is being recalled should stop using, distributing, or dispensing the affected lot and return to place of purchase.

Consumers with questions regarding this recall can contact Aurobindo Pharma USA Pharmacovigilance group at (732) 839 9400 Option 2 or PVG@aurobindousa.com Monday through Friday, 8:30AM to 5:00PM EST. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Jeffery Jackowski
VP- Quality Assurance and Compliance
Aurobindo Pharma USA
6 Wheeling Road,
Dayton NJ 08810
Phone: (732) 839 9417
jjackowski@aurobindousa.com

Photo - http://photos.prnewswire.com/prnh/20141123/160442

This press release was sent by EXPECT ADVERTISING, INC. on behalf of Aurobindo Pharma USA. For more information, please visit www.expectad.com.


'/>"/>
SOURCE Aurobindo Pharma USA
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
2. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
5. Pharmaceutical Industry Service Company Awarded The UKs Most Prestigious Business Accolade in Recognition of Outstanding Achievement in International Trade
6. Academy of Managed Care Pharmacy (AMCP) Installs 2012-2013 Board of Directors
7. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
8. Simcere Pharmaceutical Group to Announce First Quarter 2012 Financial Results on Wednesday, May 9, 2012
9. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
10. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
11. Amgen to Acquire Mustafa Nevzat, a Leading Privately Held Turkish Pharmaceutical Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2018)... ... September 14, 2018 , ... Today, ... showcases the innovative work being done within rare diseases research diagnostics and highlights ... with rare diseases. , The print component of "Rare Diseases" ...
(Date:9/15/2018)... CEDAR POINT, N.C. (PRWEB) , ... September 14, 2018 , ... ... is now on the map thanks to Hurricane Florence. I am planning this Women ... it while living out of a suitcase and knowing I have to hold onto ...
(Date:9/13/2018)... ... September 13, 2018 , ... The ultimate fitness experience has hit Astoria. A ... new arrival is called Form50 Fitness . , The studio practices the Lagree ... - a hybrid Pilates reformer with pulleys, weights, grasps and glides. The method and ...
Breaking Medicine Technology:
(Date:9/22/2018)... ... 2018 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... event held each year during Blood Cancer Awareness Month. , This year’s event ...
(Date:9/15/2018)... ... September 14, 2018 , ... Today, Mediaplanet announces the ... innovative work being done within rare diseases research, diagnostics, and will highlight what ... rare diseases. , Clay Matthews, Super Bowl-winning linebacker for the ...
(Date:9/13/2018)... , ... September 13, 2018 , ... ... honoring National Gum Care Month to educate their patients and the general public ... advanced equipment and procedures. Not only do Drs. Nash have extensive training in ...
(Date:9/13/2018)... ... , ... Pulsara is honored to be represented by its CEO, Dr. James ... in Chicago. Dr. Woodson, ER Physician and Founder/CEO of Pulsara, has been invited ... Communication & Collaboration (CC&C) is Not Enough: Why You Need a Regional Communication Network.” ...
(Date:9/12/2018)... ... September 12, 2018 , ... Today, Sterling , ... Maureen Beck, attempted the first unassisted adaptive climb of the Lotus Flower Tower in ... made it difficult for him to lead, the duo decided to persevere and with ...
Breaking Medicine News(10 mins):